Q--CONTRACT PACKET FOR CAREDX INC (FORMERLY XDX) REFERENCE LAB FOR BASE YEAR BEGINNING SEPT 1, 2017 THROUGH AUGUST 31, 2018

The Department of Veterans Affairs located at 1639 Medical Center Parkway, Suite 400, Murfreesboro, TN 37129, NCO 9 intends to negotiate a sole source contract with Caredx Inc. (XDX Inc.), 3260 Bayshore Blvd., Brisbane, CA 94005 for AlloMap Transplant Rejection Blood Testing services on behalf of the Tennessee Valley Healthcare VA Medical Facilities, Heart Transplant Department. The North American Industry Classification System (NAICS) code for this acquisition is 541380. The contract will be awarded as a firm fixed price contract for one base period with four optional renewal periods. The Contractor will provide genetic blood testing, an AlloMap Molecular Expression test only offered by this reference laboratory, to determine if a heart post-transplant patient is rejecting its transplanted organ. This notice of intent is not a request for competitive quotes. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. This type of mapping is only offered by Caredx Inc, and there are no other reference laboratory companys, who offer this specialty molecular mapping test service approved by the FDA. Therefore, responses from other than the above sources may identify their interest and capabilities to perform the requirement by submitting it in writing via email to contact@example.gov no later than July 14, 2017 by 9:00 AM Central Standard Time. The Government will not pay for any information submitted by respondents because of this notice of intent.